Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroprotection Following Cardiac Arrest: A Randomized Control Trial of Magnesium

NCT06455514 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT06455514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06455514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroprotection Following Cardiac Arrest: A Randomized Control Trial of Magnesium
Lead sponsor
NYU Langone Health
Phase
Phase 1
Overall status
Recruiting
Start date
March 25, 2025
Completion date
June 30, 2026
Enrollment
178 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrest, return of spontaneous circulation